On the occasion of World Tuberculosis (TB) Day, 24 March 2012, the European and Developing Countries Clinical Trials Partnership (EDCTP) has published a short video that highlights some of the EDCTP funded TB research in sub-Saharan Africa.
In addition, this article presents several areas of development: new diagnostic tools, shorter treatment periods, prevention of TB, and safe treatment combinations in TB-HIV co-infected patients.
Saved once (save)Bookmarked by The Editorial Team on 27 Mar 2012
Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous populationby S. A. Hadi et al.
After nearly a century of vaccination and six decades of drug therapy, tuberculosis (TB) kills more people annually than any other infectious disease. Substantial challenges to disease eradication remain among vulnerable and underserved populations. The Guarani-Kaiowá people are an indigenous population in Paraguay and the Brazilian state of Mato Grosso do Sul. This community, marginalized in Brazilian society, experiences severe poverty.
Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africaby Nomonde R Dlamini-Mvelase, Lise Werner, Rogerio Phili, Lindiwe P Cele and Koleka P Mlisana
Rapid and Inexpensive Detection of MDR Mycobacterium tuberculosis using a Resazurin Microtitreplate Assay in a High Burden Tuberculosis Reference Laboratoryby Prenika Jaglal, Melendhran Pillay, Koleka Mlisana
This review, written by Ruth McNerney and Peter Daley, provides an overview of the state of research into point-of-care diagnostics for active tuberculosis and highlights the barriers to the development of these tests.